Skip to main content

Matthew W. Tikonoff


[email protected]



Matt represents public and private companies and investors in a range of transactional and corporate matters, with a focus on mergers and acquisitions, capital markets transactions, securities law compliance and general corporate representation.  His experience includes advising clients in strategic acquisitions and divestitures, including private equity transactions, carve-out transactions and complex earn-out arrangements, as well as representing closely-held companies in exit transactions.  He also advises issuers in capital markets transactions, including initial public offerings.  Matt has experience counseling clients in a number of industries, including life sciences, medical technology, telecommunications, technology and retail.

During law school, he served as Articles Editor of the Suffolk University Law Review.


  • Suffolk University Law School (JD, magna cum laude)
  • Boston College (BA)


Mergers & Acquisitions

  • Philips Healthcare in connection with numerous acquisitions and other strategic transactions
  • Netsmart Technologies, a health information technology provider, in its acquisitions of Lavender & Wyatt Systems and Trend Consulting Services
  • Belmont Instrument Corporation, a leading provider of fluid warming infusion systems, in its recapitalization transaction with Audax Private Equity
  • Jacqueline's Wholesale Bakery, Inc., a leading manufacturer of frozen cookie dough for the in-store bakery and foodservice channels, in connection with its sale to Rich Product Corporation
  • Molecular Templates, Inc. in its merger with Threshold Pharmaceuticals, Inc. (NASDAQ: THLD)
  • Associated Home Care, a private-duty home health aide provider, in its sale to Amedisys (NASDAQ: AMED)
  • Frazier Healthcare Ventures, a middle-market private equity firm, in its acquisition of a medical footware company
  • SiOnyx, a semiconductor process company, in its acquisition by a leading private equity firm
  • Edgile, a cybersecurity consulting firm, in a minority investment transaction with a leading private equity firm
  • A privately-held distributor of industrial supplies in its sale to a strategic competitor
  • Essilor International, an eyewear company, in its acquisition of Costa (NASDAQ: ATX)
  • FGX International, an eyewear company, in its acquisition of Stylemark
  • Dynasil Corporation of America (NASDAQ: DYSL) in the sale of its cancer medical probe business to Dilon Technologies and the sale of its x-ray fluorescence lead paint detector business to Protec
  • PTC (NASDAQ: PTC) in its acquisition of Enigma Information Systems
  • Ampersand Capital Partners in its acquisitions of numerous portfolio companies

Securities Offerings

  • Spero Therapeutics, Inc. (NASDAQ: SPRO) in its $75 million follow-on offering 5.2
  • Spero Therapeutics, Inc. (NASDAQ: SPRO) in its $83.6 million initial public offering 5.1
  • WAVE Life Sciences (NASDAQ: WVE) in its $102 million initial public offering
  • Lamar Advertising Company (NASDAQ: LAMR) in Rule 144A debt offerings and follow-on exchange offers
  • Stemline Therapeutics (NASDAQ: STML) in its $30 million initial public offering

Recent Insights

News & Press


Viewpoint General
This article reviews the Delaware Court’s Akorn decision, which allowed a buyer to escape an acquisition transaction because of a material adverse change affecting the seller’s business.

News & Press

M&A bar gleans lessons from blowup of $4.75B pharma deal

March 4, 2019 | Massachusetts Lawyers Weekly

This in-depth article discusses the closely-watched Akorn, Inc. v. Fresenius Kabi AG lawsuit. The decision, allowing a German drug company to pull out of $4.75 billion deal to acquire a U.S. competitor, came from the Delaware Chancery Court – a key voice for businesses and their attorneys. Mintz Members Bret Leone-Quick and Matt Tikonoff are quoted extensively throughout the article providing third-party commentary.